Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Gross Profit (2020 - 2025)

Neuroone Medical Technologies' Gross Profit history spans 10 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 18.63% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $4.8 million, up 74.52%, while the annual FY2025 figure was $5.1 million, 376.2% up from the prior year.
  • Gross Profit reached $1.6 million in Q4 2025 per NMTC's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.9 million in Q4 2024 to a low of -$36223.0 in Q1 2022.
  • Average Gross Profit over 5 years is $405726.6, with a median of $167358.5 recorded in 2023.
  • Peak YoY movement for Gross Profit: tumbled 71.49% in 2022, then soared 3899.56% in 2023.
  • A 5-year view of Gross Profit shows it stood at -$13096.0 in 2021, then grew by 6.02% to -$12307.0 in 2022, then skyrocketed by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then decreased by 18.63% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Gross Profit are $1.6 million (Q4 2025), $1.5 million (Q3 2025), and $914835.0 (Q2 2025).